| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/16/1996 | US5508037 Stable suppository formulations effecting bioavailability of Δ9 -THC |
| 04/16/1996 | US5508034 Method and composition for treating and preventing dry skin disorders |
| 04/16/1996 | US5508030 Creating new capillary blood pools for practicing bidirectional medicine |
| 04/16/1996 | US5508026 Sunscreen agents |
| 04/16/1996 | CA2018230C Aqueous folinate solution - stable at refrigerator temperature, as well as process for its preparation |
| 04/16/1996 | CA1338245C Compound dc-107 and process for its preparation |
| 04/12/1996 | CA2160218A1 Process for obtaining procyanidol oligomers |
| 04/11/1996 | WO1996010575A1 Biologically active silicon compounds and their therapeutic and cosmetic applications |
| 04/11/1996 | WO1996010574A1 Method for preparing concentrated biologically active silicon compounds |
| 04/11/1996 | WO1996010572A1 New heterocyclic substituted imidazoloquinoxalinones, their preparation and their use |
| 04/11/1996 | WO1996010571A1 2,7-SUBSTITUTED OCTAHYDRO-1H-PYRIDO[1,2-a]PYRAZINE DERIVATIVES |
| 04/11/1996 | WO1996010568A1 Substituted aryl piperazines as neurokinin antagonists |
| 04/11/1996 | WO1996010563A1 2-aryl-4-quinolones as antitumor compounds |
| 04/11/1996 | WO1996010562A1 1-acyl-4-aliphatylaminopiperidine compounds |
| 04/11/1996 | WO1996010559A1 Urea derivatives and their use as acat-inhibitors |
| 04/11/1996 | WO1996010549A1 Compounds for the suppression of hiv tat transactivation |
| 04/11/1996 | WO1996010474A1 Razor cartridges comprising wound healing compositions |
| 04/11/1996 | WO1996010416A1 DRUGS CONTAINING β-INTERFERON |
| 04/11/1996 | WO1996010408A1 Cardioactive compounds isolated from woody perennials |
| 04/11/1996 | WO1996010407A1 Use of 9-deoxy prostaglandin derivatives to treat glaucoma |
| 04/11/1996 | WO1996010406A1 Pharmaceutical composition of fantofarone for oral administration |
| 04/11/1996 | WO1996010404A1 Antineoplastic cocoa extracts, methods for making, using |
| 04/11/1996 | WO1996010403A1 Use of retinoid glycosides in topical pharmaceutical compositions |
| 04/11/1996 | WO1996010399A1 Liposome-formulations for treatment of viral diseases |
| 04/11/1996 | WO1996010397A1 Oral sustained-release preparation |
| 04/11/1996 | WO1996010389A1 Pharmaceutical composition |
| 04/11/1996 | WO1996005866A3 Live vaccine for the treatment of tumour diseases |
| 04/11/1996 | WO1996005854A3 Combination preparation, containing cyclosporin a or fk506 or rapamycin and a xanthine derivative |
| 04/11/1996 | WO1996005845A3 Treatment of disease and conditions associated with macrophage infiltration in particular stroke and myocardial infarction |
| 04/11/1996 | WO1996005838A3 Combined preparation for the therapy of immune diseases |
| 04/11/1996 | WO1996005797A3 Agent for external application with nutrient and protective properties |
| 04/11/1996 | DE4436164A1 New conjugates of tetra:carbohydrate and amide-linked peptide or dye etc. |
| 04/11/1996 | DE4435661A1 Mittel zur Behandlung von Papillomvirus-positiven gutartigen, malignen und prämalignen Läsionen Agents for the treatment of papilloma virus-positive benign, malignant and pre-malignant lesions |
| 04/11/1996 | DE4435525A1 Compsn. for treating demyelinating encephalitis and for protective immunostimulation |
| 04/11/1996 | DE4431175A1 Neue, Chelatbildner enthaltende Arzneimittel New, high chelating drugs |
| 04/11/1996 | CA2201294A1 Use of 9-deoxy prostaglandin derivatives to treat glaucoma |
| 04/11/1996 | CA2200981A1 Urea derivatives and their use as acat-inhibitors |
| 04/11/1996 | CA2200358A1 New heterocyclic substituted imidazoloquinoxalinones, their preparation and their use |
| 04/11/1996 | CA2199621A1 Substituted aryl piperazines as neurokinin antagonists |
| 04/11/1996 | CA2199154A1 The use of medicaments containing interferon-beta |
| 04/11/1996 | CA2198382A1 1-acyl-4-aliphatylaminopiperidine compounds |
| 04/11/1996 | CA2197327A1 Oral sustained-release preparation |
| 04/11/1996 | CA2160214A1 1-arylalkenyl 4-arylmethyl piperazine structure-like derivatives; process for preparing them and pharmaceutical compositions containing them |
| 04/11/1996 | CA2160100A1 Carbohydrate conjugates as inhibitors of cell adhesion |
| 04/10/1996 | EP0705845A2 Process of simultaneous removal of tumor necrosis factor and bacterial lipopolysaccharides from an aqueous solution |
| 04/10/1996 | EP0705839A1 Imidobisphosphoric acids, process for their preparation and their use |
| 04/10/1996 | EP0705835A1 Quinoxalic-2,3-diones with an oxa or thiaheterocyclic fused ring |
| 04/10/1996 | EP0705834A1 Quinoxaline-2,3-diones with an azaheterocyclic fused ring |
| 04/10/1996 | EP0705832A1 Serotonergic modulators |
| 04/10/1996 | EP0705831A2 Cycloalkano-indole- and -azaindole derivatives |
| 04/10/1996 | EP0705830A1 2,3-Cyclic condensed 1,4-dihydropyridines, process for their preparation and their use as K-channel modulators |
| 04/10/1996 | EP0705828A1 Quinolone- and naphthyridone carboxylic acid derivatives as antibacterial agents |
| 04/10/1996 | EP0705827A1 Interleukin-1 inhibiting manumycin derivatives and streptomyces strains for their production |
| 04/10/1996 | EP0705820A1 6-Amino-nicotinic acid derivatives and their use as selective K-channel modulators |
| 04/10/1996 | EP0705819A1 1,4-Dihydropyridin-3,5-dicarboxylates and their use as selective K-channel modulators |
| 04/10/1996 | EP0705817A1 New cannamide derivatives and their use as allergy inhibitors |
| 04/10/1996 | EP0705816A1 Benzene derivative useful for ischemic diseases |
| 04/10/1996 | EP0705607A2 Condensed seven- or eight-membered heterocyclic compounds useful as antihypertriglyceridemic agents |
| 04/10/1996 | EP0705606A1 Use of 5-Thia-1,4-diazabicyclo [4.2.0] octane-3,8-dioxo compounds in antitumor therapy |
| 04/10/1996 | EP0705605A2 Use of fatty acid esters against superinfections |
| 04/10/1996 | EP0705604A2 Dermatologic compositions containing a mixture of wool wax acids against superinfections |
| 04/10/1996 | EP0705603A1 Use of non-toxic cysteine sulfoxide derivatives in the treatment of cancer or for enhancing the T-cell count |
| 04/10/1996 | EP0705602A2 Use of alpha, omega-alcanoic dicarboxylic acids against superinfections |
| 04/10/1996 | EP0705601A1 Anthraquinones containing solutions for parenteral administration |
| 04/10/1996 | EP0705600A1 Use of 5-HT1F-receptor agonists for the treatment of migraine |
| 04/10/1996 | EP0705433A1 Compositions and methods for anti-addictive narcotic analgesis acivity screening and treatments |
| 04/10/1996 | EP0705335A1 Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection |
| 04/10/1996 | EP0705273A1 17-halogeno-4-azaandrostene derivatives and process for the preparation thereof |
| 04/10/1996 | EP0705272A1 Novel process for preparing 17 beta-substituted 4-azaandrostane derivatives |
| 04/10/1996 | EP0705270A1 Chemically modified oligonucleotide for site-directed mutagenesis |
| 04/10/1996 | EP0705266A1 Process for producing imidazole derivative |
| 04/10/1996 | EP0705265A1 Novel chemical compounds having pde-iv inhibition activity |
| 04/10/1996 | EP0705264A1 Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents |
| 04/10/1996 | EP0705261A1 Antiproliferative naphthyridines |
| 04/10/1996 | EP0705260A1 Condensed 4-aminopyridines with antirheumatic activity |
| 04/10/1996 | EP0705259A1 Phenyrrole derivatives and their use as dopamine d3 antagonists |
| 04/10/1996 | EP0705258A1 Azolyl-cyclic amine derivatives with immunomodulatory activity |
| 04/10/1996 | EP0705257A1 Aminoacid derivatives as no synthase inhibitors |
| 04/10/1996 | EP0705255A1 N-morpholino-n-nitrosaminoacetonitril cyclodextrin inclusion complexes |
| 04/10/1996 | EP0705251A1 Imidazole derivatives as therapeutic agents |
| 04/10/1996 | EP0705250A1 Bis-imide polycyclic and heterocyclic chromophores useful as tumoricidals |
| 04/10/1996 | EP0705248A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 04/10/1996 | EP0705247A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 04/10/1996 | EP0705246A1 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 04/10/1996 | EP0705245A1 Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 04/10/1996 | EP0705244A1 Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system |
| 04/10/1996 | EP0705111A1 Agent with influences hyperactive immunological effector cells |
| 04/10/1996 | EP0705103A1 Use of triterpenesaponins, such as notoginsenoside r1 (r1) and/or astragaloside (iv) for preparing medicaments |
| 04/10/1996 | EP0705102A1 Use of corrinoids in topical treatment of skin diseases |
| 04/10/1996 | EP0705100A1 Therapeutic substituted guanidines |
| 04/10/1996 | EP0705099A1 Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin |
| 04/10/1996 | EP0705098A1 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders |
| 04/10/1996 | EP0705059A1 Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption |
| 04/10/1996 | EP0649429A4 Heteroatomic oligonucleoside linkages. |
| 04/10/1996 | EP0543919B1 Use of heterocyclic amino-alcohol compounds in the manufacture of a medicament for treatment of cns diseases |
| 04/10/1996 | EP0516811B1 Euthanasia compositions |
| 04/10/1996 | EP0512095B1 Methyl pyrrolidinone chitosan, production process and uses thereof |
| 04/10/1996 | EP0507870B1 Polyhemoglobin stabilized by purine derivatives and glutathione |
| 04/10/1996 | EP0504254B1 The use of gibberellins for the manufacture of a medicament for the treatment of prostatitis |
| 04/10/1996 | EP0450095B1 Method of assaying d-vanillylmandelic acid, and reagent and kit therefor |